Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 510)
Posted On: 06/30/2021 9:49:48 PM
Post# of 154993
Posted By: ohm20
Re: kabonk #94763
Quote:
Can anyone help me out here? I thought low migration of intermediate monocytes was the proposed cause of PASC, so why would reducing the migration further with LL help the condition?



A very low state of CCL4 exists in Covid increasing the non-classical monocytes which differentiate from classical when reintroduced into the bone marrow. The blocking of CCL4 by leronlimab would lower that further very insignificantly. The viral particles are shed and introduced into non-classical monocytes during the Covid active phase.

In longhaulers the low state of CCL4 exists with again a very insignificant amount of difference caused by leronlimab. Those viral particle containing non-classical monocytes will not use CCL4 as a chemotaxi and leronlimab will block the CCL5. In addition CCR5 blockade downregulates TNF-a and IFNy which are necessary for fracktaline production. TNF-a is also necessary for non-classical monocytes for endothelial cell adhesion.













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site